Anal Irrigation Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Anal Irrigation Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Anal Irrigation Systems Market is poised to grow at a CAGR of 3% by 2027.

The COVID-19 outbreak has adversely affected the anal irrigation market in all the major regions in the world as the focus of the healthcare and medical device industry has shifted from their primary businesses to developing and supplying sustainable solutions for the management of this pandemic. In addition, the adverse impact on logistics, hampering the import/export and supply chains, is also expected to obstruct the growth of the anal irrigation systems market. Anal irrigation systems had probably been the hardest hit subspecialty in urology with a massive cut down in outpatient urological investigations and procedures and urological operations. For instance, in May 2021, as per the national library of medicine, there is a decline in the number of cases, increased vaccinations, and large (>50%) declines in outpatient visits from March 2020 to April 2020 across patient demographic groups and states, regardless of the timing of state stay-at-home orders. Thus, thee COVID-19 would have a significant impact on market growth.

The anal irrigation systems market will show steady growth due to the increasing incidence of colorectal cancer and inflammatory bowel disease, the minimally invasive nature of therapy, and increasing technological advancements. For instance, in April 2021, the International Agency for Research on Cancer (IARC) estimates that in 2020 colorectal cancer was the third most commonly diagnosed cancer type in the world, with almost 2 million new cases. It was the third most common cancer in men but the second most common cancer in women, after breast cancer. Colorectal cancer was also the second most common cause of cancer death worldwide, causing almost 1 million deaths. Additionally, in April 2021, as per the Indian Journal of Medical Research, Inflammatory bowel disease (IBD) diagnosis is essentially based on classical symptomatology, endoscopy, and radiological and histological findings 1 2. In 10-15 percent of cases, it is difficult to distinguish between the two and referred to as unclassified IBD and when diagnosis is not possible even in a resected bowel specimen, this is referred to as indeterminate colitis. Thus, the rising cases of such diseases are gernating the need for the product driving the market growth.

The increasing geriatric population across the globe is found to be more prone to constipation, fecal incontinence, and other neurological conditions that help to drive the anal irrigation systems market. For instance, In October 2021, as per the World Health Organization by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Anal irrigation systems are also used among patients with neurological disorders such as spinal cord injury, multiple sclerosis, Parkinson's disease, Alzheimer's disease, brain tumors, chronic fecal incontinence, chronic constipation, and for bedridden patients and children unable to pass stool regularly and properly. The effectiveness of anal irrigation systems over conservative bowel management methods stimulates the growth of the anal Irrigation systems market. Moreover, research and innovations stimulate new product launches create new opportunities for the growth of the anal irrigation systems market.

Key Market TrendsBalloon Catheter Devices is Expected to Dominate the Anal Irrigation Systems Market During the Forecast Period

Balloon catheter systems are found to dominate the product segment as they are more suitable for patients who have difficulty keeping a cone in place or need a better seal to instill the irrigation water and are designed to use over the toilet. As bed systems are closed anal irrigation systems and suitable for patients who are unable to sit over the toilet. The balloon catheters are found to be more convenient to carry anywhere and suitably fit in with a changing lifestyle. The segment is expected to maintain a high market share over the forecast period.

Demand for balloon catheters is expected to increase owing to the rising prevalence of anal fissures across the globe. Balloon catheters are used to treat various types of anal injury, including Faecal incontinence and chronic constipation as a diagnostic imaging procedure to assess a patient's anal function. As a source for these treatments, balloon catheters are gaining immense traction. On account of this, the segment is projected to witness significant growth over the forecast period. The Centers for Disease Control and Prevention article titled ‘National Center for Health Statistics published on 15th July 2022 stated that Chronic idiopathic constipation (CIC) is a common functional disorder associated with an impaired quality of life (QoL),1 with a negative impact on social and professional life, and with a heavy economic burden.2–5 CIC affects about 10–17% of the world population, with a higher prevalence among females and elderly people,6,7 and may cause disabling symptoms. Thus, the high burden of Faecal incontinence and chronic constipation is driving the growth of the market.

Prevalence of urinary tract infections is higher among the elderly. Hence, balloon catheters are predicted to be widely employed in the elderly population, which will boost the market. In June 2022, As per the national library of medicine, Urinary tract infections are very frequent bacterial infections in women. They usually occur between the ages of 16 and 35 years, with 10% of women getting an infection yearly and more than 40% to 60% having an infection at least once in their lives. Recurrences are common, with nearly half getting a second infection within a year. Urinary tract infections occur at least four times more frequently in females than males.

While the increasing product launches are further propelling the market growth. For instance, Medtronic PLC, in July 2021 introduced a novel type of catheter into their large arsenal, a balloon catheter which can elute drugs at the target site. This product introduced into the European market for CAD by the name of Prevail Drug Coated Balloon, improves the pushability of the catheter as well as its deliverability into the complex anatomies. The drug on the balloon gets absorbed into the target arterial tissue and tries to decrease the chances of in-stent restenosis.

Thus, the aforementioned factors are propelling the market groth.

North America is Found Leading the Anal Irrigation Systems Market

North America has been dominating the global anal irrigation systems market and is expected to be a prominent region in terms of market share over the forecast period. The market in the region is expected to expand at a rapid pace due to robust healthcare infrastructure, a significant presence of major players in the region, technological advancements, and easy availability of systems with a doctor's prescription. In addition, the presence of a large number of the patient population with inflammatory bowel diseases, early adoption of new technologies, and high health care expenditure by the public and private sectors also helps propel the market growth. In August 2021, as per World Health Organization, there are approximately 70,000 new cases of Inflammatory bowel disease being diagnosed every year in the United States, and this high rate of inflammatory bowel disease cases is increasing every year which has helped in the overall growth of the market.

Furthermore, the rising prevalence of kidney and urinary tract diseases and the growing geriatric population is fueling regional growth. For instance, in April 2021, the prevalence of kidney disease in the United States, as many as 9 in 10 people who have chronic kidney diseases are not aware they have the disease. Early-stage kidney disease usually has no symptoms, and many people don’t know they have chronic kidney disease until it is very advanced. Kidney disease often gets worse over time and may lead to kidney failure and other health problems, such as stroke or heart attack. Approximately 2 in 1,000 Americans are living with end-stage kidney disease (ESKD) kidney failure which is treated with a kidney transplant or dialysis. The number of older people enrolled in Medicaid in the United States in 2021 is 6.6 million whereas the projected number of older people with Alzheimer’s in the United States in 2030 is estimated to be 8.5 millions. Thus, the rising prevalence of the aforementioned diseases and the aging population are driving market growth.

However, according to the United States Department of Health and Human Services, the overall prevalence of chronic kidney disease among the American adult population is about 16.2% in the year 2020, and almost half of the individuals with chronic kidney disease suffer from diabetes and/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis are also some of the main factors ensuring the dominance of the region. Thus, the aforementioned factors are driving the growth of the region.

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies have helped in boosting the growth of the market. Various strategies and collaborations are being adopted by these key players to maintain their market share. The key player operating in the market are Consure Medical Pvt. Ltd., ConvaTec Group PLC, Becton, Dickinson, and Company, Renew Medical Pty Ltd. (Aquaflush Medical Limited), Coloplast A/S, B. Braun Melsungen AG, MBH-International A/S, Wellspect HealthCare A, Emerson (ProSys International Ltd) and ABC Medical, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.